Medi-Exametazim is for diagnostic use only. After radiolabelling with sodium pertechnetate (99mTc) solution, the solution of technetium (99mTc) exametazime obtained is indicated for:

  • Diagnostic study of cerebrovascular disease in conjunction with the use of single photon emission tomography (SPECT)

  • Labelled leucocyte scintigraphy: In infectious or inflammatory diseases, the diagnostic target is tissue or structures in which labeled leukocytes are retained

Danish Marketing Authorisation No.: DK. R. 49482.

For more detailed information regarding Medi-Exametazim, please refer to the manufacturer's fact sheet and the Summary of Product Characteristics.

Fact Sheet

Summary of Product Characteristics for MEDI-EXAMETAZIM